On Monday 12th May, Ali gave evidence at the first APPG Inquiry into pancreatic cancer research. This is the first of four meetings taking place over the next five months:
- Monday 9th June at 3pm in Parliament’s Committee Room 6
- Monday 7th July at 3pm in Parliament’s Committee Room 5
- Monday 8th September at 2pm in Parliament’s Committee Room 5
All MPs are entitled to attend. There was a poor turnout of MPs at the first inquiry session so please do encourage your local MP to attend and take part. You are also invited to attend.
- An inquiry into how cancer research funds are distributed between cancer types and why pancreatic cancer receives such a low proportion
- Develop a Pancreatic Cancer Research Strategy in the UK to involve all stakeholders
- Increased levels of government funding to plug the gap for pancreatic cancer
- Invest a greater proportion of research funding into early diagnosis – in particular in the search for a diagnostic biomarker
- Ensure that global collaboration is formalised to prevent duplication of effort (and wasted funds)
- Encourage large cancer research funders such as Cancer Research UK to commit a firm monetary value on their proposed commitment to increase funding where there is identified unmet need (such as pancreatic cancer)
- Encourage greater pharmaceutical/industry research investment in pancreatic cancer
- Change some nihilistic attitudes among funders that pancreatic cancer is not a lost cause
Read the PCA evidence to APPG Inquiry PC Research full report to find out more.
The report looks at the issues relating to the fact that pancreatic cancer has been chronically underfunded for decades, the link to funding and low survival rate and a comparison with other cancers which have received higher levels of funding. In some cases, research funding for some cancers has seen a significant uplift in survival rates.
It also discusses comparisons of pancreatic cancer funding across the world. While proportions of pancreatic cancer research funds in the USA, Canada, Australia and parts of Europe are similar to those in the UK relative to total cancer research funding although the amount of funds in terms of dollars spent are significantly greater.
We will keep you updated with the outcome of each meeting.